Skip to content
10-Q

Quarterly Report

ACCELERON PHARMA INC.

0001280600-21-000066

← back to feed
Filed
Aug 5, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jul 31, 2021 60.9M sh
Shares Diluted Q2 2021 · Jun 30, 2021 60.72M sh
Shares Diluted Q2 2021 · Jun 30, 2021 60.52M sh
Shares Diluted Q2 2021 · Jun 30, 2020 53.86M sh
Shares Diluted Q2 2021 · Jun 30, 2020 53.61M sh
Capex Q2 2021 · Jun 30, 2021 $1.89M
Capex Q2 2021 · Jun 30, 2020 $2.42M
Operating Cash Flow Q2 2021 · Jun 30, 2021 −$152.34M
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$89.4M
Short Term Investments Q2 2021 · Jun 30, 2021 $287.15M
Short Term Investments Q2 2021 · Dec 31, 2020 $178.95M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $336.2M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $670.95M
Cash And Equivalents Q2 2021 · Jun 30, 2020 $283.52M
Stockholders Equity Q2 2021 · Jun 30, 2021 $763.03M
Stockholders Equity Q2 2021 · Mar 31, 2021 $810.83M
Stockholders Equity Q2 2021 · Dec 31, 2020 $855.11M
Stockholders Equity Q2 2021 · Jun 30, 2020 $421.62M
Stockholders Equity Q2 2021 · Mar 31, 2020 $413.82M
Stockholders Equity Q2 2021 · Dec 31, 2019 $449.48M
Current Liabilities Q2 2021 · Jun 30, 2021 $59.48M
Current Liabilities Q2 2021 · Dec 31, 2020 $60.16M
Total Liabilities Q2 2021 · Jun 30, 2021 $73.02M
Total Liabilities Q2 2021 · Dec 31, 2020 $77.23M
Current Assets Q2 2021 · Jun 30, 2021 $717.77M
Current Assets Q2 2021 · Dec 31, 2020 $893.27M
Total Assets Q2 2021 · Jun 30, 2021 $836.05M
Total Assets Q2 2021 · Dec 31, 2020 $932.34M
Eps Diluted Q2 2021 · Jun 30, 2021 −$1.05
Eps Diluted Q2 2021 · Jun 30, 2021 −$2.10
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.34
Eps Diluted Q2 2021 · Jun 30, 2020 −$1.29
Eps Basic Q2 2021 · Jun 30, 2021 −$1.05
Eps Basic Q2 2021 · Jun 30, 2021 −$2.10
Eps Basic Q2 2021 · Jun 30, 2020 −$0.34
Eps Basic Q2 2021 · Jun 30, 2020 −$1.29
Sga Expense Q2 2021 · Jun 30, 2021 $35.47M
Sga Expense Q2 2021 · Jun 30, 2021 $66.53M
Sga Expense Q2 2021 · Jun 30, 2020 $20.41M
Sga Expense Q2 2021 · Jun 30, 2020 $38.66M
Rd Expense Q2 2021 · Jun 30, 2021 $56.13M
Rd Expense Q2 2021 · Jun 30, 2021 $113.43M
Rd Expense Q2 2021 · Jun 30, 2020 $38.25M
Rd Expense Q2 2021 · Jun 30, 2020 $75.92M
Net Income Q2 2021 · Jun 30, 2021 −$63.52M
Net Income Q2 2021 · Jun 30, 2021 −$126.99M
Net Income Q2 2021 · Mar 31, 2021 −$63.47M
Net Income Q2 2021 · Jun 30, 2020 −$18.45M
Net Income Q2 2021 · Jun 30, 2020 −$69.39M
Net Income Q2 2021 · Mar 31, 2020 −$50.94M
Operating Income Q2 2021 · Jun 30, 2021 −$63.66M
Operating Income Q2 2021 · Jun 30, 2021 −$127.27M
Operating Income Q2 2021 · Jun 30, 2020 −$18.91M
Operating Income Q2 2021 · Jun 30, 2020 −$70.48M
Revenue Q2 2021 · Jun 30, 2021 $27.94M
Revenue Q2 2021 · Jun 30, 2021 $52.7M
Revenue Q2 2021 · Jun 30, 2020 $39.75M
Revenue Q2 2021 · Jun 30, 2020 $44.1M